What is the company's size? (Annual sales and employees)
What industry is the company in?
Trademark Applications
Trademark applications show the products and services that S&B Pharma is developing and marketing.
S&B Pharma doesn't have any recent trademark applications, indicating S&B Pharma is focusing on
its existing business rather than expanding into new products and markets.
Trademarks may include brand names, product names, logos and slogans.
Trademark
Date
NORAC PHARMA Chemical products, namely, organic peroxides[ for use in the plastics, resins, high polymer, laminating, casting, molding, pultrusion, extrusion, pharmaceutical, automotive, mining supply, flour, and natural oils industries, ]metallic stearates for use in the[ plastics, resins, cement, cosmetic, explosive, ink, lacquer, oil, paint, paper, ]pharmaceutical,[ rubber, varnish, wax, metal-working, powdered metal, and textile] industries, and organic chemical intermediates promoted and sold for value added treatment in the pharmaceutical manufacturing industry
02/28/2002
N NORAC PHARMA Bulk pharmaceuticals, namely, active and excipient chemical ingredients promoted and sold for further value added treatment in the pharmaceutical manufacturing industry, and organic chemical intermediates promoted and sold for value added treatment in the pharmaceutical manufacturing industry
03/16/2001
See all trademarks and details in the Full Report.
Recession Risk
Determine whether S&B Pharma grew or shrank during the last recession. This is useful in estimating the
financial strength and credit risk of the company.
Compare how recession-proof S&B Pharma is relative to the industry overall.
While a new recession may strike a particular industry, measuring the
industry and company's robustness during the last recession estimates its ability to weather future recessions.
A competitive analysis shows these companies are in the same general field as S&B Pharma, even though they may not compete head-to-head.
These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines.
The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies.
Competitive advantage comes from offering better pricing or superior products/service.
These companies are similar in business line and location to S&B Pharma.
While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.
These companies are in the same general field as S&B Pharma and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.